Match!
Geum-Youn Gwak
Samsung Medical Center
190Publications
24H-index
2,191Citations
Publications 190
Newest
#1Dong Hyun Sinn (SMC: Samsung Medical Center)H-Index: 21
#2Danbee Kang (SKKU: Sungkyunkwan University)H-Index: 8
Last.Geum-Youn Gwak (SMC: Samsung Medical Center)H-Index: 24
view all 7 authors...
Background Recently, the concept of “late presentation with viral hepatitis” was introduced to help quantify the proportion of patients missing timely diagnosis and treatment for viral hepatitis. The clinical implications of late presentation of hepatitis B at the population level, however, are largely unexplored.
Source
#1Dong Hyun Sinn (SMC: Samsung Medical Center)H-Index: 21
#2Danbee Kang (SKKU: Sungkyunkwan University)H-Index: 8
Last.Geum-Youn Gwak (SMC: Samsung Medical Center)H-Index: 24
view all 11 authors...
2 CitationsSource
#1Myung Ji Goh (SMC: Samsung Medical Center)
#2Dong Hyun Sinn (SMC: Samsung Medical Center)H-Index: 21
Last.Seung Woon Paik (SMC: Samsung Medical Center)H-Index: 39
view all 12 authors...
Source
#1Dong Hyun Sinn (SMC: Samsung Medical Center)H-Index: 21
#2Danbee Kang (SKKU: Sungkyunkwan University)H-Index: 8
Last.Geum-Youn Gwak (SMC: Samsung Medical Center)H-Index: 24
view all 12 authors...
Source
#1Dong Hyun Sinn (SKKU: Sungkyunkwan University)H-Index: 21
#2Danbee Kang (SKKU: Sungkyunkwan University)H-Index: 8
Last.Geum-Youn Gwak (SKKU: Sungkyunkwan University)H-Index: 24
view all 7 authors...
Source
#1Tae‐Se Kim (SMC: Samsung Medical Center)H-Index: 1
#2Dong Hyun Sinn (SMC: Samsung Medical Center)H-Index: 21
Last.Seung Woon Paik (SMC: Samsung Medical Center)H-Index: 39
view all 9 authors...
1 CitationsSource
#1Young Suk Lim (UOU: University of Ulsan)H-Index: 18
#2Geum-Youn Gwak (SMC: Samsung Medical Center)H-Index: 24
Last.Han Chu Lee (UOU: University of Ulsan)H-Index: 37
view all 9 authors...
Background & Aims Tenofovir disoproxil fumarate (TDF) monotherapy has displayed non-inferior efficacy to TDF plus entecavir (ETV) combination therapy in patients with hepatitis B virus (HBV) resistant to ETV and/or adefovir (ADV). Nonetheless, the virologic response rate was suboptimal in patients receiving up to 144 weeks of TDF monotherapy. We aimed to assess the efficacy and safety of TDF monotherapy given for up to 240 weeks. Methods One trial enrolled patients with ETV resistance without AD...
2 CitationsSource
Source
#1Jonggi ChoiH-Index: 6
#2Young-Suk LimH-Index: 4
Last.Geum-Youn GwakH-Index: 24
view all 9 authors...
Source
#1Ji Hye Kim (SMC: Samsung Medical Center)H-Index: 19
#2Dong-Hyun Sinn (SMC: Samsung Medical Center)H-Index: 2
Last.Seung Woon Paik (SMC: Samsung Medical Center)H-Index: 39
view all 9 authors...
Background and aim Currently, sorafenib is indicated for hepatocellular carcinoma (HCC) with extrahepatic metastasis (EHM), and many other systemic agents are becoming available. However, a few HCC patients with EHM still undergo transarterial chemoembolization (TACE) for intrahepatic tumor control. We aimed to investigate whether TACE is appropriate for patients with EHM, and if so, which subgroup may benefit from TACE. Methods A total of 186 consecutive HCC patients (median: 55 years, male: 86...
Source
12345678910